International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
2015 · Nature Communications · 306 citations
https://doi.org/10.1038/ncomms9019
G
George Mells
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
154
Papers
6.8K
Citations
37
h-index
63
i10-index
George Mells is an academic researcher from Cambridge University Hospitals NHS Foundation Trust. The author has contributed to research in topics: Liver Diseases and Immunity & Liver Disease Diagnosis and Treatment & Pediatric Hepatobiliary Diseases and Treatments. The author has an h-index of 37, co-authored 131 publications.
ORCID: 0000-0002-7962-5286Papers by this author
worksSevere steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury
2017 · ESMO Open · 121 citations
https://doi.org/10.1136/esmoopen-2017-000268
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis
2021 · Gastroenterology · 51 citations
https://doi.org/10.1053/j.gastro.2021.02.061
Calcineurin Inhibitors and the IL12A Locus Influence Risk of Recurrent Primary Biliary Cirrhosis After Liver Transplantation
2013 · American Journal of Transplantation · 49 citations
https://doi.org/10.1111/ajt.12132
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison
2021 · Journal of Translational Autoimmunity · 23 citations
https://doi.org/10.1016/j.jtauto.2021.100081
Anti–Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct–Ligated Mice
2022 · American Journal Of Pathology · 15 citations
https://doi.org/10.1016/j.ajpath.2022.09.005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat